期刊文献+

冠心病合并慢性心力衰竭患者GDF15、BNP、sST2的表达及其与心功能的相关性 被引量:16

Expression of GDF15, BNP and sST2 in Patients with Coronary Heart Disease Complicated with Chronic Heart Failure and Its Correlation with Cardiac Function
下载PDF
导出
摘要 目的研究冠心病合并慢性心力衰竭患者生长分化因子15(growth differentiation factor 15,GDF15)、脑利钠肽(brain natriuretic peptide,BNP)、可溶性ST2(soluble ST2,sST2)的表达及其与心功能的相关性。方法选取2014年1月—2018年1月我院收治的82例冠心病合并慢性心力衰竭患者作为观察组,根据纽约心脏病协会心功能分级标准,分为心功能Ⅱ级组(n=16)、心功能Ⅲ级组(n=46)、心功能Ⅳ级组(n=20)。选取60例同期于我院进行健康体检的健康者作为对照组。检测GDF15、BNP、sST2水平及心功能相关指标,分析GDF15、BNP和sST2与心功能的相关性。结果与对照组比较,观察组GDF15、BNP、sST2、左室前后径(left anterior and posterior diameter,LAD)、左室舒张末期内径(left ventricular end diastolic diameter,LVEDD)和左室心肌质量指数(left ventricular myocardial mass index,LVMI)上升,左室相对室壁厚度(left ventricular relative wall thickness,RWT)和左室射血分数(left ventricular ejection fraction,LVEF)降低,差异有统计学意义(P<0.01)。不同心功能的冠心病合并慢性心力衰竭患者GDF15、BNP、sST2、LAD、LVEDD、LVMI、RWT和LVEF比较均有统计学意义(P<0.05);与心功能Ⅱ级组比较,心功能Ⅲ级组、心功能Ⅳ级组GDF15、BNP、sST2、LAD、LVEDD和LVMI升高,RWT和LVEF降低,差异有统计学意义(P<0.05);与心功能Ⅲ级组比较,心功能Ⅳ级组GDF15、BNP、sST2、LAD、LVEDD和LVMI明显上升,RWT和LVEF显著降低,差异有统计学意义(P<0.05)。Pearson相关性分析显示,GDF15、BNP和sST2与心功能均呈正相关(P<0.05)。结论冠心病合并慢性心力衰竭患者GDF15、BNP和sST2呈较高水平表达,且随着心功能分级的升高而逐渐上升,可作为临床评估冠心病合并慢性心力衰竭患者病情严重程度的有效指标。 Objective To investigate the expression of growth differentiation factor 15(GDF15),brain natriuretic peptide(BNP)and soluble ST2(sST2)in patients with coronary heart disease(CHD)complicated with chronic heart failure(CHF)and its correlation with cardiac function.Methods Eighty-two patients with CHD complicated with CHF who were admitted to our hospital from January 2014 to January 2018 were selected as observation group.According to the classification standard of cardiac function in New York Heart Association,they were divided into cardiac function grading II group(n=16),cardiac function grading III group(n=46),and cardiac function grading IV group(n=20).Sixty healthy people who underwent physical examination in our hospital were selected as control group.GDF15,BNP,sST2 levels and related indicators of cardiac function were measured,and the correlation between GDF15,BNP,sST2 and cardiac function was analyzed.Results Compared with the control group,GDF15,BNP,sST2,left anterior and posterior diameter(LAD),left ventricular end diastolic diameter(LVEDD)and left ventricular myocardial mass index(LVMI)in the observation group were increased,while left ventricular relative wall thickness(RWT)and left ventricular ejection fraction(LVEF)were decreased,and the difference was statistically significant(P<0.01).The difference in GDF15,BNP,sST2,LAD,LVEDD,LVMI,RWT and LVEF between patients with CHD and CHF and with different cardiac functions were statistically significant(P<0.05).Compared with cardiac function grading II group,GDF15,BNP,sST2,LAD,LVEDD and LVM1 were increased in cardiac function gradingⅢgroup and gradingⅣgroup,and RWT and LVEF were decreased,suggesting significant difference(P<0.05).Compared with cardiac function gradingⅢgroup,the GDF15,BNP,sST2,LAD,LVEDD and LVMI in cardiac function gradingⅣgroup were increased significantly,and the RWT and LVEF were decreased significantly(P<0.05).Pearson correlation analysis showed that GDF15,BNP and sST2 were positively correlated with cardiac function(P<0.05).Conclusion GDF15,BNP and sST2 are highly expressed in patients with CHD complicated with CHF,and the levels gradually increase with the increasing of cardiac function grading.Therefore,it can be used as an effective indicator for clinical evaluation of the severity of disease in CHD patients with CHF.
作者 张建霞 杨培亮 王焕 ZHANG Jian-xia;YANG Pei-liang;WANG Huan(Department of Cardiology,Central Hospital in Weinan,Weinan,Shaanxi 714000,China;Department of Cardiology,Huazhou District People's Hospital in Weinan,Weinan,Shaanxi 714100,China)
出处 《临床误诊误治》 2019年第12期67-71,共5页 Clinical Misdiagnosis & Mistherapy
基金 陕西省社会发展科技攻关项目(2014SF097)
关键词 冠心病 心力衰竭 生长分化因子15 利钠肽 Coronary disease Heart failure Growth differentiation factor 15 Natriuretic peptide brain
  • 相关文献

参考文献20

二级参考文献159

  • 1许婷媛,常彬宾,彭华生,何晓英,钟景烨,梁国君,赵涛.别嘌呤醇对伴高尿酸血症老年慢性心力衰竭患者心功能的影响[J].实用老年医学,2013,27(1):29-31. 被引量:19
  • 2Yasser Mahrous Fouad,Reem Yehia.Hepato-cardiac disorders[J].World Journal of Hepatology,2014,6(1):41-54. 被引量:10
  • 3盖延红,李越凡,栾晓东.慢性心力衰竭患者的CRP、BNP的水平变化和临床意义[J].河北医学,2006,12(10):964-967. 被引量:5
  • 4凌佳,蔡振荣,胡春燕,等.慢性心力衰竭患者检测血清同型半胱氨酸与B型脑钠肽的临床意义[J].中外健康文摘,2012,9(45):172.
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35:1076-1095.
  • 6Katz AM. Regression of left ventricular hypertrophy : New hope for dy- ing hearts [J]. Circulation, 1998,98 (7) :623-624.
  • 7Xu J,Kimball TR,Lorenz JN,et al. GDF-15/MIC-1 functions as aprotective and antihypertrophic factor released from the myocardi-am in association with SMAD protein ctivation[J]. Circ res,2006,98(3):342-350. doi:10.1161/01.RES. 00002028 04. 84885.d0.
  • 8Brown DA,Breit SN,Bu ring J,et al. Concentration in plasma ofmacrophage inhibitory cytokin1 and risk of cardiovascular enents inwomen a nested case control syudy[J]. Lancet,2002,359(9324):2159-2163. doi:10.1016/ S0 140-6736(02)09093-1.
  • 9Kempf T,von Haehling S,Peter T,et al. Prognostic Utility of growthdifferentiation factor 15 in Patients With Chronic Heart Failure[J].J Am Coll Cardiol,2007,50(11):1054- 1060. doi:10.1016/ j.jacc.2007.04.091.
  • 10Lind L,Wallentin L,Kempf T,et al. Growth differention factor-15is an independent marker of cardiovascular dysfunction and diseasein the elderly:results from the Prospective Investigation of the Vas-culature in Uppsala Seniors(POVUS) Study[J]. Eur Heart J,2009,30(19):2346-2353. doi:10.1093/eurheartj/ehp261.

共引文献391

同被引文献179

引证文献16

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部